Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Trailblazing TRAIL Therapy: Illuminating Pathways for Cholangiocarcinoma Treatment

Cellular and Molecular Gastroenterology and Hepatology(2024)10.1016/j.jcmgh.2024.02.008Source: DataRank Database

Trailblazing TRAIL Therapy: Illuminating Pathways for Cholangiocarcinoma Treatment is a research paper published in Cellular and Molecular Gastroenterology and Hepatology (2024). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.42)OA: goldTopics (15)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (1)

Sungjin Ko ORCID

Live enrichment

PubMed:38431266 OpenAlex:https://openalex.org/W4392288260

NIH

Grant: R01CA258449

NIH

Grant: P30DK120531

National Institutes of Health

Grant: 1R01CA258449-01

Identifying therapeutic options for intrahepatic cholangiocarcinoma

National Institutes of Health

Grant: 1P30DK120531-01

Pittsburgh Liver Research Center

FWCI

0.42

Citation Percentile

0.6%

Citation Trend

2025

goldLicense: CC BY NC ND

journalhttps://doi.org/10.1016/j.jcmgh.2024.02.008

publisherhttps://doi.org/10.1016/j.jcmgh.2024.02.008

publisherhttps://api.elsevier.com/content/article/PII:S2352345X24000365?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2352345X24000365?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38431266

Fields of Study

Cholangiocarcinoma and Gallbladder Cancer StudiesPediatric Hepatobiliary Diseases and TreatmentsPeptidase Inhibition and Analysis03 medical and health sciences0302 clinical medicine

MeSH Terms

Bile Duct NeoplasmsBile Ducts, IntrahepaticHumansCholangiocarcinoma

Keywords

MedicineCholangiocarcinomaEditorialBile Ducts, IntrahepaticBile Duct NeoplasmsHumans

Sustainable Development Goals

SDG 0: Good health and well-being